Arnab Chatterjee

Arnab Chatterjee (PhD, Caltech 2002) is Vice President of Medicinal Chemistry at the Calibr-Skaggs Institute for Innovative Medicines in La Jolla, CA. His career spans 20+ years in drug discovery across infectious diseases, respiratory illnesses, oncology, and regenerative medicine.

Research Expertise

• Development of novel synthetic methods for structural diversification
• Cell-based lead optimization
• Preclinical ADME and pharmacokinetics
• Translational research in infectious diseases

Scientific Contributions

His work has produced 8 preclinical candidates (3 first-in-class) including Ganaplacide (Phase 3 malaria) and CMX990 (SARS-CoV-2 3CL protease inhibitor). Recent research integrates AI with traditional screening for accelerated drug discovery.

Scientific Awards

• Translational Science Award
• Pilot Study Award